Publications

Nikkilä J, Kumar R, Campbell J, Brandsma I, Pemberton HN, Wallberg F, Nagy K, Scheer I, Vertessy BG, Serebrenik AA, Monni V, Harris RS, Pettitt SJ, Ashworth A, Lord CJ. Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. British journal of cancer. 2026. PMID: 41699262

Nkya A, Xu MJ, Philipo GS, Haddadi S, Ng D, Mushi BP, Malango AE, Magorosa EP, Paciorek A, Zhang L, Muya S, Ha P, Liyombo E, Richard E, Massawe W, Palefsky JM, Yom SS, Mmbaga EJ, Van Loon K. Prevalence of High-Risk Human Papillomavirus and Associated Risk Factors Among Individuals With Head and Neck Cancer in a National Referral Center in Tanzania. JCO global oncology. 2026. PMID: 41843836

Delaveris CS, Loudermilk RP, Pandey A, Remesh SG, Peters-Clarke TM, Ganjave SD, Dougherty WJN, Delavan HM, Wang C, Ling J, Camara Serrano JA, Salangsang F, Ding CC, Greenland N, Chu CE, Porten S, Steri V, Chou J, Evans MJ, Leung KK, Wells JA. Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer. Science (New York, N.Y.). 2026. PMID: 41818370

Vijayaraghavan M, Williams A, Bonniot C, Cheng C, Clark B, Safier J, Satterfield J, Pamatmat M, Schroeder SA. State Leadership Academies to Reduce Tobacco Use Prevalence in the United States: Four Case Studies of Early State Adopters of Tobacco Treatment and Policy. Public health reports (Washington, D.C. : 1974). 2026. PMID: 41797633

Nadine Goldhammer, Marin Bont, Shruti Warhadpande, Michael Choi, Jose Cedano, Heather Greenwood, Julia Ye, Christopher Schwartz, Michael Alvarado, Cheryl Ewing, Karen Goodwin, Rita Mukhtar, Jasmine Wong, Shoko Abe, Julia Chandler, Jordan Jackson, Olufunmilayo Olopade, Michael Campbell, Allison Lam, Chaelee Park, Anna Vertido, Laura van 't Veer, Nola Hylton, Laura Esserman, Jennifer Rosenbluth. Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue bioRxiv. 2026. PMID:

Corona M, García-Vicente R, Saez-Marin AJ, Ancos-Pintado R, Rodríguez-Garcia A, Arroyo A, Blanco A, Chari A, Martin T, Wolf J, Rey-Bua B, Mateos MV, Kortüm KM, Riedhammer C, Tamariz-Amador LE, Valencia E, Rodríguez-Otero P, San Miguel J, Ibarra G, Oriol A, Cedena MT, López-Muñoz N, Alonso R, Calbacho M, Sanchez-Pina JM, Linares M, Martínez-López J. Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma. Journal for immunotherapy of cancer. 2026. PMID: 41791791

Kim J, Munster PN. Cracks in the Estrogen Carcinogenesis of Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026. PMID: 41785447

Slovin S, Gao X, Wei XX, Oh DY, McKay RR, Falchook G, Hussain A, McKean M, Wibmer A, Ho A, Eskew JD, Belani R, Coronella J, Haag S, Martin CE, McCaigue J, Mendoza J, Murphy A, Namini H, Spear MA, Shedlock DJ, Dorff TB. Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC). Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41779004

Chrostek MR, Robinson J, Krishnan R, Yu EY, Nordquist LT, Vandross AL, Salkeni MA, Schehr J, Mannino M, Hintz A, Caceres J, Vatani M, Emamekhoo H, Nelson P, Markey C, Coates E, Breitmeyer J, Fong L, De Bono JS, Lang JM, Zhao SG. Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534. Investigational new drugs. 2026. PMID: 41774321

Rugo HS, Cescon DW, Robson ME, Im SA, Dalenc F, Yañez Ruiz E, Reyes-Cosmelli F, Walshe JM, Im YH, Kulyk S, Dudnichenko O, Llinás-Quintero N, Saji S, Miyoshi Y, Bardia A, Harbeck N, Haiderali A, Fan L, Mejia JA, Karantza V, Llombart-Cussac A. KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41405563

Wan J, Saatcioglu HD, Ellis H, Aguado-Fraile E, Xu Q, Kondo H, Manguso RT, Gritti I, Norden BL, Noble C, Corcoran RB, Lubner SJ, Javle M, Abou-Alfa GK, Cleary JM, Kelley RK, Borad MJ, Macarulla T, Oh DY, Daigle S, Gliser C, Pandya S, Choe S, Tron AE, Bardeesy N. MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41460204

Hammer MJ, Harris C, Pozzar R, Snowberg K, Paul SM, Cooper BA, Abbott ME, Chang S, Kenfield S, Van Blarigan E, Van Loon K, Levine JD, Miaskowski C. Symptom Clusters and Symptom Burden in Cancer Survivors. Cancer medicine. 2026. PMID: 41787680

Chan SL, Yau T, Kelley RK, Finn RS, Yoo C, Furuse J, Ren Z, Klümpen HJ, Ozaka M, Pelzer U, Arslan C, Park JO, Edeline J, Valle JW, Ueno M, Vogel A, Starkopf L, Malhotra U, Siegel AB, Qin S. Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study. Cancer Research Communications. 2026. PMID: 41757470

Correia N, Johnson K, Durr M, Grimes BA, Lazar AA, Sarkar U, Ha PK, Chen L, Wai KC, Likhterov I, Yom SS, Chan JW, Algazi AP, Kang H, Ryan WR, Heaton CM, El-Sayed I, George J, Xu MJ. Timely Matters: Predictors of Delay in Oral Cavity Cancer Patients Across the Care Continuum. Laryngoscope investigative otolaryngology. 2026. PMID: 41767548

L'Espérance K, Lin K, Lichtensztajn D, Christoph Soerensen SJ, Gulati S, Deng Z, Leppert JT, Oh DY, Sakoda LC, Washington SL, Meng MV, Chan JM, Langston ME, Cheng I, Chung BI, Graff RE. Renal cell carcinoma incidence and mortality in California: a population-based study of sociodemographic patterns and temporal trends from 1988 through 2019. Lancet regional health. Americas. 2026. PMID: 41800233

Armstrong AJ, Morris MJ, Abida W, Aggarwal RR, Antonarakis ES, Attard G, Beltran H, Bryce A, Carducci MA, Cheng HH, Chen DL, Chi KN, Childs DS, Dahut W, Emmett L, Fizazi K, Gafita A, George DJ, Hermann K, Hofman MS, Hope T, Hussain M, Kelly WK, Kessler E, Kuo PH, Lang J, Liu G, Marshall CH, Morgans AK, McKay RR, Nanus D, Nelson P, Paller C, Reichert ZR, Ryan CJ, Sartor AO, Schöder H, Schwartz LH, Sharifi N, Stadler WM, Stein M, Sternberg CN, Szmulewitz RZ, Tagawa ST, Sokolova AO, Wyatt AW, Yamoah K, Yu EY, Halabi S, Scher HI, PCWG4 Writing Group. Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026. PMID: 41744290

Ma RK, Tsai PY, Farghli AR, Shumway A, Kanke M, Gordan JD, Gujral TS, Vakili K, Nukaya M, Noetzli L, Ronnekleiv-Kelly S, Broom W, Barrow J, Sethupathy P. Correction: DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma. PLoS genetics. 2026. PMID: 41746900

Rugo HS. Hitting the Mark - Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer. The New England journal of medicine. 2026. PMID: 41740036

Shah NJ, Sura S, Shinde R, Dai W, Wentworth C, Conkling P, Bupathi M, Vickery D, Perini R, Motzer RJ. Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study. Urologic oncology. 2026. PMID: 41760529

Gyawali B, Bohlke K, Dickter JK, Kelkar AH, Knopf KB, Rapoport BL, Roof L, Schott S, Seshadri MR, Shilpakar R, Smith TJ, Trapani D, Woodard AB, Cigler T. WBC Growth Factors: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2026. PMID: 41740078